A
1.65
-0.15 (-8.33%)
Penutupan Terdahulu | 1.80 |
Buka | 1.77 |
Jumlah Dagangan | 242,984 |
Purata Dagangan (3B) | 83,204 |
Modal Pasaran | 23,982,914 |
Harga / Jualan (P/S) | 48.84 |
Harga / Buku (P/B) | 0.180 |
Julat 52 Minggu |
Margin Operasi (TTM) | -2,621.65% |
EPS Cair (TTM) | -2.76 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 109.90% |
Nisbah Semasa (MRQ) | 0.100 |
Aliran Tunai Operasi (OCF TTM) | -27.17 M |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | Adagio Medical Holdings, Inc | - | - |
AISkor Stockmoo
0.6
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 2.5 |
Osilator Teknikal | -0.5 |
Purata | 0.63 |
Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia. |
|
Sektor | Healthcare |
Industri | Medical Devices |
% Dimiliki oleh Orang Dalam | 19.66% |
% Dimiliki oleh Institusi | 91.48% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
16 Dec 2024 | Pengumuman | Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director |
14 Nov 2024 | Pengumuman | Adagio Medical Reports Third Quarter 2024 Results |
04 Nov 2024 | Pengumuman | Adagio Medical to Present at the Stifel 2024 Healthcare Conference |
24 Oct 2024 | Pengumuman | Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System |
07 Oct 2024 | Pengumuman | Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |